pharma media measurement

Digital

Welcome to the era where the convergence of quantum computing and artificial intelligence isn't just an advantage, it's the imperative.

News

Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.